MSL2_HUMAN - dbPTM
MSL2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MSL2_HUMAN
UniProt AC Q9HCI7
Protein Name E3 ubiquitin-protein ligase MSL2
Gene Name MSL2
Organism Homo sapiens (Human).
Sequence Length 577
Subcellular Localization
Protein Description Component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at lysine 16 which is implicated in the formation of higher-order chromatin structure. Acts as an E3 ubiquitin ligase that promotes monoubiquitination of histone H2B at 'Lys-35' (H2BK34Ub), but not that of H2A. This activity is greatly enhanced by heterodimerization with MSL1. H2B ubiquitination in turn stimulates histine H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1..
Protein Sequence MNPVNATALYISASRLVLNYDPGDPKAFTEINRLLPYFRQSLSCCVCGHLLQDPIAPTNSTCQHYVCKTCKGKKMMMKPSCSWCKDYEQFEENKQLSILVNCYKKLCEYITQTTLARDIIEAVDCSSDILALLNDGSLFCEETEKPSDSSFTLCLTHSPLPSTSEPTTDPQASLSPMSESTLSIAIGSSVINGLPTYNGLSIDRFGINIPSPEHSNTIDVCNTVDIKTEDLSDSLPPVCDTVATDLCSTGIDICSFSEDIKPGDSLLLSVEEVLRSLETVSNTEVCCPNLQPNLEATVSNGPFLQLSSQSLSHNVFMSTSPALHGLSCTAATPKIAKLNRKRSRSESDSEKVQPLPISTIIRGPTLGASAPVTVKRESKISLQPIATVPNGGTTPKISKTVLLSTKSMKKSHEHGSKKSHSKTKPGILKKDKAVKEKIPSHHFMPGSPTKTVYKKPQEKKGCKCGRATQNPSVLTCRGQRCPCYSNRKACLDCICRGCQNSYMANGEKKLEAFAVPEKALEQTRLTLGINVTSIAVRNASTSTSVINVTGSPVTTFLAASTHDDKSLDEAIDMRFDC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
7Phosphorylation-MNPVNATALYISAS
-CCCCCHHHEEEEHH
16.4023663014
10PhosphorylationPVNATALYISASRLV
CCCHHHEEEEHHEEE
7.1423663014
12PhosphorylationNATALYISASRLVLN
CHHHEEEEHHEEECC
13.4623663014
14PhosphorylationTALYISASRLVLNYD
HHEEEEHHEEECCCC
21.2523663014
20UbiquitinationASRLVLNYDPGDPKA
HHEEECCCCCCCHHH
21.2529967540
20PhosphorylationASRLVLNYDPGDPKA
HHEEECCCCCCCHHH
21.2519605366
26UbiquitinationNYDPGDPKAFTEINR
CCCCCCHHHHHHHHH
61.95-
29PhosphorylationPGDPKAFTEINRLLP
CCCHHHHHHHHHHHH
40.59-
78AcetylationKGKKMMMKPSCSWCK
CCCEEEECCCCHHCC
18.8426051181
85UbiquitinationKPSCSWCKDYEQFEE
CCCCHHCCCHHHHHH
58.0229967540
94UbiquitinationYEQFEENKQLSILVN
HHHHHHHHHHHHHHH
56.7629967540
104AcetylationSILVNCYKKLCEYIT
HHHHHHHHHHHHHHH
41.287692255
105UbiquitinationILVNCYKKLCEYITQ
HHHHHHHHHHHHHHH
31.71-
109PhosphorylationCYKKLCEYITQTTLA
HHHHHHHHHHHHHHH
14.3124719451
113PhosphorylationLCEYITQTTLARDII
HHHHHHHHHHHHHHH
18.3524719451
114PhosphorylationCEYITQTTLARDIIE
HHHHHHHHHHHHHHH
14.49-
137PhosphorylationLALLNDGSLFCEETE
HHHHCCCCCEEEECC
22.5732142685
149PhosphorylationETEKPSDSSFTLCLT
ECCCCCCCCEEEEEE
31.5226074081
150PhosphorylationTEKPSDSSFTLCLTH
CCCCCCCCEEEEEEC
27.5226074081
152PhosphorylationKPSDSSFTLCLTHSP
CCCCCCEEEEEECCC
20.6426074081
156PhosphorylationSSFTLCLTHSPLPST
CCEEEEEECCCCCCC
21.2226074081
158PhosphorylationFTLCLTHSPLPSTSE
EEEEEECCCCCCCCC
23.9326074081
162PhosphorylationLTHSPLPSTSEPTTD
EECCCCCCCCCCCCC
52.8526074081
163PhosphorylationTHSPLPSTSEPTTDP
ECCCCCCCCCCCCCC
34.8626074081
164PhosphorylationHSPLPSTSEPTTDPQ
CCCCCCCCCCCCCCC
46.0126074081
211PhosphorylationRFGINIPSPEHSNTI
CCCCCCCCCCCCCCC
38.8430266825
215PhosphorylationNIPSPEHSNTIDVCN
CCCCCCCCCCCEECC
33.7230266825
217PhosphorylationPSPEHSNTIDVCNTV
CCCCCCCCCEECCCE
22.9030266825
223PhosphorylationNTIDVCNTVDIKTED
CCCEECCCEECCHHH
17.9028450419
228PhosphorylationCNTVDIKTEDLSDSL
CCCEECCHHHHHCCC
34.7628270605
261UbiquitinationCSFSEDIKPGDSLLL
ECCCCCCCCCCEEEE
56.10-
277UbiquitinationVEEVLRSLETVSNTE
HHHHHHHCCCCCCCE
5.3129967540
301UbiquitinationLEATVSNGPFLQLSS
CEEEECCCCCEEEEC
13.5629967540
325UbiquitinationSTSPALHGLSCTAAT
CCCHHHHCCCCCCCC
21.8229967540
335UbiquitinationCTAATPKIAKLNRKR
CCCCCHHHHHHHHHC
4.2630230243
343PhosphorylationAKLNRKRSRSESDSE
HHHHHHCCCCCCCCC
43.1023401153
345PhosphorylationLNRKRSRSESDSEKV
HHHHCCCCCCCCCCC
42.5730266825
347PhosphorylationRKRSRSESDSEKVQP
HHCCCCCCCCCCCCC
47.9230266825
349PhosphorylationRSRSESDSEKVQPLP
CCCCCCCCCCCCCCC
48.9030266825
351UbiquitinationRSESDSEKVQPLPIS
CCCCCCCCCCCCCCE
50.5529967540
358PhosphorylationKVQPLPISTIIRGPT
CCCCCCCEEEEECCC
16.1823927012
359PhosphorylationVQPLPISTIIRGPTL
CCCCCCEEEEECCCC
22.5723927012
363UbiquitinationPISTIIRGPTLGASA
CCEEEEECCCCCCCC
14.7729967540
365PhosphorylationSTIIRGPTLGASAPV
EEEEECCCCCCCCCE
40.4223312004
369PhosphorylationRGPTLGASAPVTVKR
ECCCCCCCCCEEEEC
31.1625159151
373PhosphorylationLGASAPVTVKRESKI
CCCCCCEEEECCCCC
21.1732142685
375UbiquitinationASAPVTVKRESKISL
CCCCEEEECCCCCCE
40.8729967540
375AcetylationASAPVTVKRESKISL
CCCCEEEECCCCCCE
40.8725953088
375SumoylationASAPVTVKRESKISL
CCCCEEEECCCCCCE
40.8728112733
375SumoylationASAPVTVKRESKISL
CCCCEEEECCCCCCE
40.87-
376UbiquitinationSAPVTVKRESKISLQ
CCCEEEECCCCCCEE
49.4329967540
379UbiquitinationVTVKRESKISLQPIA
EEEECCCCCCEEEEE
31.40-
380UbiquitinationTVKRESKISLQPIAT
EEECCCCCCEEEEEE
7.4729967540
387PhosphorylationISLQPIATVPNGGTT
CCEEEEEECCCCCCC
36.9028122231
393PhosphorylationATVPNGGTTPKISKT
EECCCCCCCCCCCEE
41.1225159151
394PhosphorylationTVPNGGTTPKISKTV
ECCCCCCCCCCCEEE
26.3425159151
399UbiquitinationGTTPKISKTVLLSTK
CCCCCCCEEEEECCC
46.2429967540
400PhosphorylationTTPKISKTVLLSTKS
CCCCCCEEEEECCCC
15.03-
404PhosphorylationISKTVLLSTKSMKKS
CCEEEEECCCCCHHH
29.6324719451
406AcetylationKTVLLSTKSMKKSHE
EEEEECCCCCHHHHC
45.2225953088
406UbiquitinationKTVLLSTKSMKKSHE
EEEEECCCCCHHHHC
45.22-
409UbiquitinationLLSTKSMKKSHEHGS
EECCCCCHHHHCCCC
59.2130230243
419PhosphorylationHEHGSKKSHSKTKPG
HCCCCCCCCCCCCCC
36.41-
421PhosphorylationHGSKKSHSKTKPGIL
CCCCCCCCCCCCCCC
49.46-
435UbiquitinationLKKDKAVKEKIPSHH
CCCCHHHHHHCCCCC
59.1429967540
437UbiquitinationKDKAVKEKIPSHHFM
CCHHHHHHCCCCCCC
54.9529967540
440PhosphorylationAVKEKIPSHHFMPGS
HHHHHCCCCCCCCCC
32.8229255136
447PhosphorylationSHHFMPGSPTKTVYK
CCCCCCCCCCCCEEC
24.4323401153
449PhosphorylationHFMPGSPTKTVYKKP
CCCCCCCCCCEECCC
40.8329255136
450UbiquitinationFMPGSPTKTVYKKPQ
CCCCCCCCCEECCCC
39.1029967540
453PhosphorylationGSPTKTVYKKPQEKK
CCCCCCEECCCCCCC
20.6517053785
454UbiquitinationSPTKTVYKKPQEKKG
CCCCCEECCCCCCCC
54.3529967540
488UbiquitinationCPCYSNRKACLDCIC
CCCCCCCCHHHHHHH
47.94-
501PhosphorylationICRGCQNSYMANGEK
HHHCCCCCHHCCCCH
7.1529978859
502PhosphorylationCRGCQNSYMANGEKK
HHCCCCCHHCCCCHH
14.0629978859
508AcetylationSYMANGEKKLEAFAV
CHHCCCCHHEEEEEC
65.1526051181
508UbiquitinationSYMANGEKKLEAFAV
CHHCCCCHHEEEEEC
65.15-
509UbiquitinationYMANGEKKLEAFAVP
HHCCCCHHEEEEECC
47.4629967540
509AcetylationYMANGEKKLEAFAVP
HHCCCCHHEEEEECC
47.4626051181
518UbiquitinationEAFAVPEKALEQTRL
EEEECCHHHHHHHHE
52.80-
518AcetylationEAFAVPEKALEQTRL
EEEECCHHHHHHHHE
52.8025953088
540PhosphorylationSIAVRNASTSTSVIN
EEEEEECCCCCEEEE
26.8330108239
541PhosphorylationIAVRNASTSTSVINV
EEEEECCCCCEEEEC
33.3527251275
542PhosphorylationAVRNASTSTSVINVT
EEEECCCCCEEEECC
19.0527251275
543PhosphorylationVRNASTSTSVINVTG
EEECCCCCEEEECCC
27.4027251275
544PhosphorylationRNASTSTSVINVTGS
EECCCCCEEEECCCC
22.2930108239
549PhosphorylationSTSVINVTGSPVTTF
CCEEEECCCCCCCEE
27.7028450419
551PhosphorylationSVINVTGSPVTTFLA
EEEECCCCCCCEEEE
13.5628450419
554PhosphorylationNVTGSPVTTFLAAST
ECCCCCCCEEEECCC
18.4028450419
555PhosphorylationVTGSPVTTFLAASTH
CCCCCCCEEEECCCC
19.5228450419
560PhosphorylationVTTFLAASTHDDKSL
CCEEEECCCCCCCCH
22.2222199227
561PhosphorylationTTFLAASTHDDKSLD
CEEEECCCCCCCCHH
25.29-
566PhosphorylationASTHDDKSLDEAIDM
CCCCCCCCHHHHHHH
48.3125849741

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MSL2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MSL2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MSL2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
P53_HUMANTP53physical
19033443
H2A2C_HUMANHIST2H2ACphysical
21726816
H2A2A_HUMANHIST2H2AA3physical
21726816
H2B2E_HUMANHIST2H2BEphysical
21726816
H32_HUMANHIST2H3Cphysical
21726816
UB2D3_HUMANUBE2D3physical
21726816
TRIM8_HUMANTRIM8physical
22493164
H2B2E_HUMANHIST2H2BEphysical
24837678
UB2D3_HUMANUBE2D3physical
24837678
BRE1A_HUMANRNF20physical
24837678
BRE1B_HUMANRNF40physical
24837678
PAF1_HUMANPAF1physical
24837678
CDK9_HUMANCDK9physical
24837678
MSL1_HUMANMSL1physical
28514442
KAT8_HUMANKAT8physical
28514442
MS3L1_HUMANMSL3physical
28514442
HBB_HUMANHBBphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MSL2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling.";
Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.;
EMBO J. 25:5058-5070(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-453, AND MASSSPECTROMETRY.

TOP